Advertisement
Research Article

Background Rates of Adverse Pregnancy Outcomes for Assessing the Safety of Maternal Vaccine Trials in Sub-Saharan Africa

  • Lauren A. V. Orenstein,

    Affiliations: Emory University School of Medicine, Atlanta, Georgia, United States of America, Centre pour le Développement des Vaccins-Mali, Bamako, Mali

    X
  • Evan W. Orenstein,

    Affiliations: Emory University School of Medicine, Atlanta, Georgia, United States of America, Centre pour le Développement des Vaccins-Mali, Bamako, Mali

    X
  • Ibrahima Teguete,

    Affiliation: Gabriel Touré Teaching Hospital, Department of Obstetrics and Gynecology, Bamako, Mali

    X
  • Mamoudou Kodio,

    Affiliation: Centre pour le Développement des Vaccins-Mali, Bamako, Mali

    X
  • Milagritos Tapia,

    Affiliations: Centre pour le Développement des Vaccins-Mali, Bamako, Mali, Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America

    X
  • Samba O. Sow,

    Affiliations: Centre pour le Développement des Vaccins-Mali, Bamako, Mali, Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America

    X
  • Myron M. Levine mail

    MLevine@medicine.umaryland.edu

    Affiliation: Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America

    X
  • Published: October 04, 2012
  • DOI: 10.1371/journal.pone.0046638

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.